Read this manager's filing book
Disclosed positions
Eleva Capital SAS: source evidence dated 2026-07-03T03:59:59.999Z.
- Issuer
- CRH PLC
- Ticker
- CRH
- Class
- ORD
- Reported value
- $279,090,866
- Reported amount
- 2,654,974
- Unit
- SH
- Option
- None
The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.
What was reported for this quarter?
13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.
SEC 13F-HR: 0002054496-26-000003Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filings
Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filingsKeep reporting dates and units beside the answer, and inspect its original citations.
Disclosed positions
See the complete disclosed positions
| CRH PLC | CRH | ORD | $279,090,866 | 2,654,974 | SH | None |
| AMER SPORTS INC | AS | COM SHS | $9,836,562 | 298,802 | SH | None |
| NVIDIA CORPORATION | NVDA | COM | $9,069,148 | 52,002 | SH | None |
| NETFLIX INC | NFLX | COM | $8,383,319 | 87,190 | SH | None |
| ALPHABET INC | GOOGL | CAP STK CL A | $8,042,191 | 27,967 | SH | None |
| TAIWAN SEMICONDUCTOR MFG LT | TSM | SPONSORED ADS | $6,506,589 | 21,411 | SH | None |
| ARISTA NETWORKS INC | ANET | COM SHS | $5,765,380 | 46,957 | SH | None |
| AMAZON COM INC | AMZN | COM | $3,364,601 | 16,155 | SH | None |
| T-MOBILE US INC | TMUS | COM | $3,013,300 | 14,347 | SH | None |
| ROBINHOOD MKTS INC | HOOD | COM CL A | $2,191,613 | 31,625 | SH | None |
| ON HLDG AG | ONON | NAMEN AKT A | $1,706,103 | 50,150 | SH | None |
| BOSTON SCIENTIFIC CORP | BSX | COM | $1,673,354 | 26,667 | SH | None |
| SPOTIFY TECHNOLOGY S A | SPOT | SHS | $1,316,531 | 2,715 | SH | None |
| NEWAMSTERDAM PHARMA COMPANY | NAMS | ORDINARY SHARES | $823,329 | 25,721 | SH | None |
| CG ONCOLOGY INC | CGON | COM | $561,000 | 8,289 | SH | None |
| ESPERION THERAPEUTICS INC | ESPR | COM | $501,549 | 183,047 | SH | None |
| MINERALYS THERAPEUTICS INC | MLYS | COM | $462,724 | 17,081 | SH | None |
| FENNEC PHARMACEUTICALS INC | FENC | COM | $327,389 | 53,234 | SH | None |
| DISC MEDICINE INC | IRON | COM | $327,053 | 5,115 | SH | None |
| VIRIDIAN THERAPEUTICS INC | VRDN | COM | $139,385 | 7,126 | SH | None |
| FREEPORT MCMORAN INC | FCX | CL B | $132,725 | 2,258 | SH | None |
| ARCHER AVIATION INC | ACHR | COM CL A | $111,331 | 21,534 | SH | None |
| EDGEWISE THERAPEUTICS INC | EWTX | COM | $54,990 | 17,460 | SH | None |
| AQUESTIVE THERAPEUTICS INC | AQST | COM | $11,288 | 2,720 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 0 positions lack a resolved ticker and 0 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.